Home 2015
Archives
FDA Approves Unituxin for High-Risk Neuroblastoma
First approval for a therapy aimed specifically to treat the rare pediatric cancer
FDA Approves Cresemba for Serious Fungal Infections
New drug targets cell walls of the fungi; available in oral and intravenous formulations
FDA Approves New CPR Devices
Used together, they up the amount of oxygenated blood circulating through the body during CPR
FDA: Device Authorized for Use in Dialysis-Related Amyloidosis
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
FDA Approves First Biosimilar Drug in U.S.
Zarxio is highly similar to long-sanctioned cancer drug
FDA Launches First App to Identify Drug Shortages
App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages
STS Releases Outcomes for Congenital Heart Sx Database
Society of Thoracic Surgeons has made data available for pediatric, congenital heart surgery
Rush University Adds Patient Scores to Doctor Profiles
Scores based on 30 or more patient surveys completed in one-year period
FDA: Opdivo Approval Expanded to Include Lung Cancer
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Resistance to Common Antimicrobials Increasing
Salmonella, Campylobacter show significant resistance in humans and animals
